Rachel Borboa
Genomics Institute of the Novartis Research Foundation(US)
Publications by Year
Research Areas
Malaria Research and Control, HIV/AIDS drug development and treatment, Computational Drug Discovery Methods, Drug Transport and Resistance Mechanisms, Mosquito-borne diseases and control
Most-Cited Works
- → Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery(2011)347 cited
- → KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission(2014)156 cited
- → Whole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genes(2010)106 cited
- → Imidazolopiperazines: Hit to Lead Optimization of New Antimalarial Agents(2011)103 cited
- → Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial Agents(2012)92 cited
- → Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds(2010)76 cited
- → KAI407, a Potent Non-8-Aminoquinoline Compound That Kills Plasmodium cynomolgi Early Dormant Liver Stage ParasitesIn Vitro(2013)69 cited
- → Lead Optimization of Imidazopyrazines: A New Class of Antimalarial with Activity on Plasmodium Liver Stages(2014)33 cited
- → Cell-based optimization of novel benzamides as potential antimalarial leads(2009)15 cited
- Disease Transmission Prophylaxis, Treatment, and Prevention of Candidate with Potential for Use in KAF156 Is an Antimalarial Clinical(2014)